Kelsee, I respectfully disagree that any "Showdown in Stockholm" hype/drama/promotion is necessary. Totally different drugs, primary mechanism of drug action, drug target, modulated endpoints (mostly), mechanism of MACE reduction and eligible patient population. See my Jardiance vs. RVX-208 post from a few minutes ago.
BDAZ